Home > Insider Trading > Filing (0001562180-17-004013)

Filing Details

Accession Number:: 0001562180-17-004013
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-22 16:02:40
Reporting Period:: 2017-12-21

Accepted Time:: 2017-12-22 16:02:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597553	Sage Therapeutics Inc.	SAGE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1042021	M Jeffrey Jonas	C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142	President & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-12-21	110,247	$0.45	211,473	No	4	M	Direct
Common Stock	Disposition	2017-12-21	36,989	$155.48	174,484	No	4	S	Direct
Common Stock	Disposition	2017-12-21	71,823	$156.55	102,661	No	4	S	Direct
Common Stock	Disposition	2017-12-21	27,152	$157.48	75,509	No	4	S	Direct
Common Stock	Disposition	2017-12-21	33,301	$158.21	42,208	No	4	S	Direct
Common Stock	Disposition	2017-12-21	22,334	$159.53	19,874	No	4	S	Direct
Common Stock	Disposition	2017-12-21	13,049	$160.36	6,825	No	4	S	Direct
Common Stock	Disposition	2017-12-21	5,000	$162.08	1,825	No	4	S	Direct
Common Stock	Disposition	2017-12-21	599	$162.59	1,226	No	4	S	Direct
Common Stock	Acquisiton	2017-12-22	12,753	$0.45	13,979	No	4	M	Direct
Common Stock	Disposition	2017-12-22	12,753	$155.00	1,226	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-12-21	110,247	$0.00	110,247	$0.45
Common Stock	Stock Option (Right to Buy)	Disposition	2017-12-22	12,753	$0.00	12,753	$0.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
295,305		2023-08-12	No	4	M	Direct
282,552		2023-08-12	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2011 Stock Option and Incentive Plan. The option fully vested on August 12, 2017, subject to continued service through such date.
This transaction was executed in multiple trades at prices ranging from $155.00 USD to $155.99 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $156.00 USD to $156.99 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $157.00 USD to $157.99 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $158.00 USD to $158.99 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $159.00 USD to $159.99 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $160.00 USD to $160.97 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $161.43 USD to $162.41 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $162.44 USD to $162.68 USD. The price reported above reflects the weighted average sale price.